JP2022526525A5 - - Google Patents
Info
- Publication number
- JP2022526525A5 JP2022526525A5 JP2021557187A JP2021557187A JP2022526525A5 JP 2022526525 A5 JP2022526525 A5 JP 2022526525A5 JP 2021557187 A JP2021557187 A JP 2021557187A JP 2021557187 A JP2021557187 A JP 2021557187A JP 2022526525 A5 JP2022526525 A5 JP 2022526525A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- inhibitor
- cancer
- composition according
- combination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2026021790A JP2026077769A (ja) | 2019-03-25 | 2026-02-13 | 癌療法のためのイアダデムスタット(iadademstat)の組み合わせ物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19382206 | 2019-03-25 | ||
| EP19382206.1 | 2019-03-25 | ||
| PCT/EP2020/058362 WO2020193631A1 (en) | 2019-03-25 | 2020-03-25 | Combinations of iadademstat for cancer therapy |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026021790A Division JP2026077769A (ja) | 2019-03-25 | 2026-02-13 | 癌療法のためのイアダデムスタット(iadademstat)の組み合わせ物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022526525A JP2022526525A (ja) | 2022-05-25 |
| JP2022526525A5 true JP2022526525A5 (cg-RX-API-DMAC10.html) | 2023-04-04 |
| JP7824627B2 JP7824627B2 (ja) | 2026-03-05 |
Family
ID=66175363
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021557187A Active JP7824627B2 (ja) | 2019-03-25 | 2020-03-25 | 癌療法のためのイアダデムスタット(iadademstat)の組み合わせ物 |
| JP2026021790A Withdrawn JP2026077769A (ja) | 2019-03-25 | 2026-02-13 | 癌療法のためのイアダデムスタット(iadademstat)の組み合わせ物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026021790A Withdrawn JP2026077769A (ja) | 2019-03-25 | 2026-02-13 | 癌療法のためのイアダデムスタット(iadademstat)の組み合わせ物 |
Country Status (13)
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG10201913290QA (en) | 2016-03-15 | 2020-03-30 | Oryzon Genomics Sa | Combinations of lsd1 inhibitors for the treatment of hematological malignancies |
| SI3941466T1 (sl) | 2019-03-20 | 2026-04-30 | Oryzon Genomics, S.A. | Vafidemstat za zdravljenje neagresivnih simptomov mejne osebnostne motnje |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9469597B2 (en) | 2011-10-20 | 2016-10-18 | Oryzon Genomics S.A. | (Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors |
| EP3090998A1 (en) | 2015-05-06 | 2016-11-09 | F. Hoffmann-La Roche AG | Solid forms |
| CN120661674A (zh) | 2016-03-15 | 2025-09-19 | 奥莱松基因组股份有限公司 | 用于治疗实体瘤的lsd1抑制剂的组合 |
| US20190256929A1 (en) * | 2016-11-03 | 2019-08-22 | Oryzon Genomics, S.A. | Pharmacodynamic biomarkers for personalized cancer care using epigenetic modifying agents |
| US11685782B2 (en) * | 2017-10-23 | 2023-06-27 | Children's Medical Center Corporation | Methods of treating cancer using LSD1 inhibitors in combination with immunotherapy |
-
2020
- 2020-03-25 EP EP20712594.9A patent/EP3946295B1/en active Active
- 2020-03-25 BR BR112021016171-6A patent/BR112021016171A2/pt unknown
- 2020-03-25 MX MX2021011610A patent/MX2021011610A/es unknown
- 2020-03-25 WO PCT/EP2020/058362 patent/WO2020193631A1/en not_active Ceased
- 2020-03-25 CN CN202080018266.2A patent/CN113573702A/zh active Pending
- 2020-03-25 PH PH1/2021/552326A patent/PH12021552326A1/en unknown
- 2020-03-25 CA CA3132473A patent/CA3132473A1/en active Pending
- 2020-03-25 CN CN202511368496.2A patent/CN121422229A/zh active Pending
- 2020-03-25 SG SG11202109025XA patent/SG11202109025XA/en unknown
- 2020-03-25 AU AU2020249493A patent/AU2020249493B2/en active Active
- 2020-03-25 KR KR1020217028840A patent/KR20210142614A/ko not_active Ceased
- 2020-03-25 JP JP2021557187A patent/JP7824627B2/ja active Active
- 2020-03-25 US US17/441,758 patent/US20220175698A1/en active Pending
-
2021
- 2021-09-13 IL IL286353A patent/IL286353A/en unknown
-
2026
- 2026-02-13 JP JP2026021790A patent/JP2026077769A/ja not_active Withdrawn